{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:40:49Z","timestamp":1781012449384,"version":"3.54.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210206"],"award-info":[{"award-number":["RP210206"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bioactmat.2023.12.027","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T18:31:37Z","timestamp":1704997897000},"page":"422-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6997-7088","authenticated-orcid":false,"given":"Serkan","family":"Yaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3431-365X","authenticated-orcid":false,"given":"Harish","family":"Ramachandramoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6509-972X","authenticated-orcid":false,"given":"Priyanka","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Chintapula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-7436","authenticated-orcid":false,"given":"Tam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3723-0315","authenticated-orcid":false,"given":"Manoj","family":"Sabnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanviben","family":"Kotadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurentiu M.","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquibul","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4455-9319","authenticated-orcid":false,"given":"Jon A.","family":"Weidanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kytai T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bioactmat.2023.12.027_bib1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/thoraxjnl-2011-200714","article-title":"Early diagnosis of lung cancer: evaluation of a community-based social marketing intervention","volume":"67","author":"Athey","year":"2012","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.bioactmat.2023.12.027_bib2","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.2003.10.038","article-title":"Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]","volume":"21","author":"Fukuoka","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib3","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.12.027_bib5","doi-asserted-by":"crossref","DOI":"10.3747\/co.27.6233","article-title":"Radiotherapy side effects: integrating a survivorship clinical lens to better serve patients","volume":"27","author":"Dilalla","year":"2020","journal-title":"Curr. Oncol."},{"issue":"21","key":"10.1016\/j.bioactmat.2023.12.027_bib6","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1016\/j.biomaterials.2013.03.061","article-title":"Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy","volume":"34","author":"Sadhukha","year":"2013","journal-title":"Biomaterials"},{"issue":"Suppl 10","key":"10.1016\/j.bioactmat.2023.12.027_bib7","doi-asserted-by":"crossref","first-page":"x52","DOI":"10.1093\/annonc\/mds347","article-title":"Developments in the treatment of early NSCLC: when to use chemotherapy","volume":"23","author":"Besse","year":"2012","journal-title":"Ann. Oncol."},{"issue":"2 Suppl 3","key":"10.1016\/j.bioactmat.2023.12.027_bib8","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1053\/j.seminoncol.2005.03.006","article-title":"Chemotherapeutic issues in the management of unresectable stage III non-small cell lung cancer","volume":"32","author":"Socinski","year":"2005","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2012.02.018","article-title":"Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients","volume":"77","author":"Ohguri","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2008.03.059","article-title":"Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes","volume":"73","author":"Ohguri","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2021.03.086","article-title":"PLGA nanoparticles containing \u03b1-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line","volume":"553","author":"Pho-iam","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.12.027_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijpharm.2011.11.043","article-title":"Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system","volume":"423","author":"Kona","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.colsurfb.2019.03.011","article-title":"Cisplatin-loaded PLGA nanoparticles for HER2 targeted ovarian cancer therapy","volume":"178","author":"Dom\u00ednguez-R\u00edos","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.12.027_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.12.027_bib15","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomed."},{"issue":"38","key":"10.1016\/j.bioactmat.2023.12.027_bib16","doi-asserted-by":"crossref","first-page":"14265","DOI":"10.1073\/pnas.0805135105","article-title":"Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts","volume":"105","author":"Lundqvist","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bioactmat.2023.12.027_bib17","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/ja107583h","article-title":"Physical\u2212 chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles","volume":"133","author":"Monopoli","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/nnm.15.188","article-title":"The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery","volume":"11","author":"Corbo","year":"2016","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.bioactmat.2023.12.027_bib19","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1039\/C5CS00699F","article-title":"In vivo degeneration and the fate of inorganic nanoparticles","volume":"45","author":"Feliu","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biocel.2016.01.005","article-title":"Protein corona: opportunities and challenges","volume":"75","author":"Zanganeh","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"90","key":"10.1016\/j.bioactmat.2023.12.027_bib21","doi-asserted-by":"crossref","first-page":"73963","DOI":"10.1039\/C5RA14870G","article-title":"Reducing the cytotoxicity of ZnO nanoparticles by a pre-formed protein corona in a supplemented cell culture medium","volume":"5","author":"Yin","year":"2015","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.toxlet.2015.10.018","article-title":"Protein corona acts as a protective shield against Fe3O4-PEG inflammation and ROS-induced toxicity in human macrophages","volume":"240","author":"Escamilla-Rivera","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib23","doi-asserted-by":"crossref","DOI":"10.1109\/IWMPI.2015.7107015","article-title":"In Formation of a biocompatible protein corona on magnetic nanoparticles","author":"Weidner","year":"2015"},{"key":"10.1016\/j.bioactmat.2023.12.027_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biocel.2016.03.016","article-title":"Protein corona: the golden gate to clinical applications of nanoparticles","volume":"75","author":"Mahmoudi","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.biocel.2015.12.015","article-title":"Dissociation coefficients of protein adsorption to nanoparticles as quantitative metrics for description of the protein corona: a comparison of experimental techniques and methodological relevance","volume":"75","author":"H\u00fchn","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biomaterials.2017.09.020","article-title":"Bio-inspired engineering of cell-and virus-like nanoparticles for drug delivery","volume":"147","author":"Parodi","year":"2017","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.bioactmat.2023.12.027_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib28","series-title":"Membrane Dynamics and Domains","first-page":"167","article-title":"Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications","author":"Barenholz","year":"2004"},{"issue":"6982","key":"10.1016\/j.bioactmat.2023.12.027_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature02388","article-title":"Designing materials for biology and medicine","volume":"428","author":"Langer","year":"2004","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bioactmat.2023.12.027_bib30","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nmat3775","article-title":"Engineering synthetic vaccines using cues from natural immunity","volume":"12","author":"Irvine","year":"2013","journal-title":"Nat. Mater."},{"issue":"14","key":"10.1016\/j.bioactmat.2023.12.027_bib31","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.addr.2006.09.014","article-title":"Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging","volume":"58","author":"Manchester","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.12.027_bib32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1073\/pnas.1010013108","article-title":"Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles","volume":"108","author":"Merkel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.bioactmat.2023.12.027_bib33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nmat3049","article-title":"Nanoparticles that communicate in vivo to amplify tumour targeting","volume":"10","author":"Von Maltzahn","year":"2011","journal-title":"Nat. Mater."},{"issue":"27","key":"10.1016\/j.bioactmat.2023.12.027_bib34","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bioactmat.2023.12.027_bib35","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS Nano"},{"issue":"30","key":"10.1016\/j.bioactmat.2023.12.027_bib36","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1002\/smll.201600624","article-title":"Stem cell membrane\u2010coated nanogels for highly efficient in vivo tumor targeted drug delivery","volume":"12","author":"Gao","year":"2016","journal-title":"Small"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.12.027_bib37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/lsm.22235","article-title":"Combined concurrent photodynamic and gold nanoshell loaded macrophage\u2010mediated photothermal therapies: an in vitro study on squamous cell head and neck carcinoma","volume":"46","author":"Trinidad","year":"2014","journal-title":"Laser Surg. Med."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib38","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/srep02180","article-title":"Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications","volume":"3","author":"Bahmani","year":"2013","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.12.027_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11060-010-0511-3","article-title":"Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells","volume":"104","author":"Baek","year":"2011","journal-title":"J. Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.12.027_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"issue":"6676","key":"10.1016\/j.bioactmat.2023.12.027_bib41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/33340","article-title":"Chemokines and leukocyte traffic","volume":"392","author":"Baggiolini","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.12.027_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bjp.0702328","article-title":"Leukocyte\u2010endothelial cell adhesion: avenues for therapeutic intervention","volume":"126","author":"Pan\u00e9s","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.12.027_bib43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0008-6363(96)00066-1","article-title":"Molecular mechanisms of leukocyte recruitment in the inflammatory process","volume":"32","author":"Ley","year":"1996","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.apsb.2017.12.001","article-title":"Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy","volume":"8","author":"Huang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.12.027_bib45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1517\/17425247.2015.966684","article-title":"Leukocytes as carriers for targeted cancer drug delivery","volume":"12","author":"Mitchell","year":"2015","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib46","unstructured":"Yaman, S.; Ramachandramoorthy, H.; Oter, G.; Zhukova, D.; Nguyen, T.; Sabnani, M. K.; Weidanz, J. A.; Nguyen, K. T., Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer. (2296-4185 (Print)."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.12.027_bib47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tibtech.2016.07.006","article-title":"Breaking down the barriers to precision cancer nanomedicine","volume":"35","author":"von Roemeling","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.12.027_bib48","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","article-title":"Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2023.12.027_bib49","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2147\/IJN.S126016","article-title":"Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer","volume":"12","author":"Zhang","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nnano.2012.212","article-title":"Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions","volume":"8","author":"Parodi","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib51","unstructured":"Ma, W.; Zhu, D.; Li, J.; Chen, X.; Xie, W.; Jiang, X.; Wu, L.; Wang, G.; Xiao, Y.; Liu, Z.; Wang, F.; Li, A.; Shao, D.; Dong, W.; Liu, W.; Yuan, Y., Coating Biomimetic Nanoparticles with Chimeric Antigen Receptor T Cell-Membrane Provides High Specificity for Hepatocellular Carcinoma Photothermal Therapy Treatment. (1838-7640 (Electronic)).."},{"issue":"12","key":"10.1016\/j.bioactmat.2023.12.027_bib52","first-page":"3173","article-title":"Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy","volume":"63","author":"Crittenden","year":"2003","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bioactmat.2023.12.027_bib53","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1021\/nl401376w","article-title":"Reconstructed stem cell nanoghosts: a natural tumor targeting platform","volume":"13","author":"Toledano Furman","year":"2013","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.12.027_bib54","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.12.027_bib55","doi-asserted-by":"crossref","first-page":"10414","DOI":"10.1021\/nn503779d","article-title":"Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy","volume":"8","author":"Piao","year":"2014","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.bioactmat.2023.12.027_bib56","first-page":"879","article-title":"Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy","volume":"3","author":"Yaman","year":"2020","journal-title":"Cancer Drug Resist."},{"issue":"12","key":"10.1016\/j.bioactmat.2023.12.027_bib57","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1038\/s41596-018-0075-9","article-title":"Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins","volume":"13","author":"Elegheert","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02595","article-title":"Ultrastructural localization and molecular associations of HCV capsid protein in jurkat T cells","volume":"8","author":"Fern\u00e1ndez-Ponce","year":"2018","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib59","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41598-020-79698-w","article-title":"Reference standards for accurate validation and optimization of assays that determine integrated lentiviral vector copy number in transduced cells","volume":"11","author":"Paugh","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib60","article-title":"Development and validation of a simple and sensitive spectrometric method for estimation of cisplatin hydrochloride in tablet dosage forms: application to dissolution studies","volume":"2013","author":"Basotra","year":"2013","journal-title":"ISRN Analyt. Chem."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib61","unstructured":"Wang, W.; Wu, F.; Mohammadniaei, M.; Zhang, M.; Li, Y.; Sun, Y.; Tang, B. Z., Genetically Edited T-Cell Membrane Coated AIEgen Nanoparticles Effectively Prevents Glioblastoma Recurrence. (1878-5905 (Electronic))."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib62","unstructured":"Liu, H. J.; Wang, M.; Shi, S.; Hu, X.; Xu, P., A Therapeutic Sheep in Metastatic Wolf\u2019s Clothing: Trojan Horse Approach for Cancer Brain Metastases Treatment. (2150-5551 (Electronic)."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12951-021-01202-x","article-title":"Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer","volume":"19","author":"Chen","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.12.027_bib64","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7150\/thno.40291","article-title":"Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment","volume":"10","author":"Ma","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2023.12.027_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23074056","article-title":"The effects of chimeric antigen receptor (CAR) hinge domain post-translational modifications on CAR-T cell activity","author":"Hirobe","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.12.027_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12265-012-9381-8","article-title":"Enhanced endothelialization of a new stent polymer through surface enhancement and incorporation of growth factor-delivering microparticles","volume":"5","author":"Xu","year":"2012","journal-title":"J. Cardio. Trans. Res."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib67","article-title":"Testing <em>in vitro<\/em> toxicity of nanoparticles in 3D cell culture with various extracellular matrix scaffold","volume":"2021","author":"Choi","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.bioactmat.2023.12.027_bib68","unstructured":"Kapa\u0142czy\u0144ska, M.; Kolenda, T.; Przyby\u0142a, W.; Zaj\u0105czkowska, M.; Teresiak, A.; Filas, V.; Ibbs, M.; Bli\u017aniak, R.; \u0141uczewski, \u0141.; Lamperska, K., 2D and 3D Cell Cultures - a Comparison of Different Types of Cancer Cell Cultures. (1734-1922 (Print)."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.12.027_bib69","article-title":"Flat cell culturing surface may cause misinterpretation of cellular uptake of nanoparticles","volume":"2","author":"Behzadi","year":"2018","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib70","unstructured":"Deng, G.; Sun, Z.; Li, S.; Peng, X.; Li, W.; Zhou, L.; Ma, Y.; Gong, P.; Cai, L. A.-O., Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth. (1936-086X (Electronic))."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib71","unstructured":"Kanaani, L.; Javadi I Fau - Ebrahimifar, M.; Ebrahimifar M; Fau - Ebrahimi Shahmabadi, H.; Ebrahimi Shahmabadi; H Fau - Akbarzadeh Khiyav, A.; Akbarzadeh Khiyav A Fau - Mehrdiba, T.; Mehrdiba, T., Effects of Cisplatin-Loaded Niosomal Nanoparticleson BT-20 Human Breast Carcinoma Cells. (2476-762X (Electronic))."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib72","doi-asserted-by":"crossref","unstructured":"Monroe, J. D.; Hodzic, D.; Millay, M. H.; Patty, B. G.; Smith, M. A.-O., Anti-cancer and ototoxicity characteristics of the curcuminoids, CLEFMA and EF24, in combination with cisplatin. LID - 10.3390\/molecules24213889 [doi] LID - 3889. (1420-3049 (Electronic)).","DOI":"10.3390\/molecules24213889"},{"key":"10.1016\/j.bioactmat.2023.12.027_bib73","doi-asserted-by":"crossref","first-page":"129+","DOI":"10.1159\/000495169","article-title":"Recovery of miR-139-5p in ovarian cancer reverses cisplatin resistance by targeting C-jun","volume":"51","author":"Jiang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib74","unstructured":"Bunn, P. A., Jr.; Helfrich B Fau - Soriano, A. F.; Soriano Af Fau - Franklin, W. A.; Franklin Wa Fau - Varella-Garcia, M.; Varella-Garcia M Fau - Hirsch, F. R.; Hirsch Fr Fau - Baron, A.; Baron A Fau - Zeng, C.; Zeng C Fau - Chan, D. C.; Chan, D. C., Expression of Her-2\/neu in Human Lung Cancer Cell Lines by Immunohistochemistry and Fluorescence in Situ Hybridization and its Relationship to in Vitro Cytotoxicity by Trastuzumab and Chemotherapeutic Agents. (1078-0432 (Print))."},{"issue":"15","key":"10.1016\/j.bioactmat.2023.12.027_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900251","article-title":"T cell membrane mimicking nanoparticles with bioorthogonal targeting and immune recognition for enhanced photothermal therapy","volume":"6","author":"Han","year":"2019","journal-title":"Adv. Sci."},{"issue":"39","key":"10.1016\/j.bioactmat.2023.12.027_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003368","article-title":"T-Cell-Mimicking nanoparticles for cancer immunotherapy","volume":"32","author":"Kang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib77","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.2147\/IJN.S148359","article-title":"Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy","volume":"12","author":"Zhang","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010077","article-title":"Immunocyte membrane-coated nanoparticles for cancer immunotherapy","volume":"13","author":"Gong","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bioactmat.2023.12.027_bib79","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.tranon.2014.04.002","article-title":"Axitinib improves radiotherapy in murine xenograft lung tumors","volume":"7","author":"Hillman","year":"2014","journal-title":"Trans. Oncol."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.12.027_bib80","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1021\/acs.nanolett.6b02786","article-title":"Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes","volume":"16","author":"Zhu","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib81","unstructured":"Yamashita, N.; Nakai, K.; Nakata, T.; Nakamura, I.; Kirita, Y.; Matoba, S.; Humphreys, B. D.; Tamagaki, K.; Kusaba, T., Cumulative DNA Damage by Repeated Low-Dose Cisplatin Injection Promotes the Transition of Acute to Chronic Kidney Injury in Mice. (2045-2322 (Electronic))."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.12.027_bib82","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib83","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","article-title":"Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment","volume":"14","author":"Zou","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioactmat.2023.12.027_bib84","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1021\/acsnano.0c02207","article-title":"Pulmonary delivery of nanoparticle-bound toll-like receptor 9 agonist for the treatment of metastatic lung cancer","volume":"14","author":"Perry","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2023.12.027_bib85","article-title":"Significant suppression of non-small-cell lung cancer by hydrophobic poly(ester amide) nanoparticles with high docetaxel loading","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2023.12.027_bib86","series-title":"Manoj Kumar Sabnani Double Sided Chimeric Antigen Receptor (CAR) Engineered Cell Membrane Based Drug Delivery System","author":"Kytai Nguyen","year":"2022"},{"key":"10.1016\/j.bioactmat.2023.12.027_bib87","unstructured":"Liu, L.; Pan, D.; Chen, S.; Martikainen, M.-V.; K\u00e5rlund, A.; Ke, J.; Pulkkinen, H.; Ruhanen, H.; Roponen, M.; K\u00e4kel\u00e4, R.; Xu, W.; Wang, J.; Lehto, V.-P., Systematic Design of Cell Membrane Coating to Improve Tumor Targeting of Nanoparticles."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.12.027_bib88","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1038\/s41467-021-26052-x","article-title":"Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X23004309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X23004309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:45:40Z","timestamp":1762785940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X23004309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":88,"alternative-id":["S2452199X23004309"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2023.12.027","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2023.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}